OTCMKTS:MCUJF Medicure (MCUJF) Stock Price, News & Analysis → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free MCUJF Stock Alerts $0.68 -0.04 (-5.56%) (As of 04/23/2024 ET) Add Compare Share Share Today's Range$0.68▼$0.6850-Day Range$0.68▼$1.0152-Week Range$0.68▼$1.26Volume126 shsAverage Volume1,873 shsMarket Capitalization$7.10 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Get Medicure alerts: Email Address Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry About Medicure Stock (OTCMKTS:MCUJF)Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company offers Sodium Nitroprusside injection for the reduction of blood pressure for adult and pediatric patients in hypertensive crisis, as well as for producing controlled hypotension to reduce bleeding during surgery, and for the treatment of acute congestive heart failure. It offers products through retail and mail order pharmacies. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada.Read More MCUJF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MCUJF Stock News HeadlinesApril 19, 2024 | americanbankingnews.comMedicure (OTCMKTS:MCUJF) Stock Price Passes Below 200 Day Moving Average of $0.97December 5, 2023 | finance.yahoo.comMedicure Announces New Partnership Through Its Marley Drug Subsidiary to Provide Brenzavvy(R) as an Affordable Medication for Americans with Type 2 DiabetesApril 24, 2024 | InvestorPlace (Ad)Elon Musk’s Controversial New Project: “Apollo”Have you seen this footage outside the headquarters of Elon Musk's "Project Apollo?" Big Tech and the mainstream media have called this project "controversial"...November 24, 2023 | msn.comMedicure approved to enrol patients in paediatric disease trialNovember 23, 2023 | benzinga.comMedicure Announces FDA Provides Complete Approval to Enroll Patients in Its Pivotal Phase 3 Trial for Treatment of Rare Pediatric DiseaseNovember 21, 2023 | msn.comMedicure GAAP EPS of C$0.01, revenue of C$5MNovember 21, 2023 | finance.yahoo.comMedicure Reports Financial Results for Quarter Ended September 30, 2023October 24, 2023 | finance.yahoo.comMedicure Inc.'s (CVE:MPH) Stock Is Going Strong: Have Financials A Role To Play?April 24, 2024 | InvestorPlace (Ad)Elon Musk’s Controversial New Project: “Apollo”Have you seen this footage outside the headquarters of Elon Musk's "Project Apollo?" Big Tech and the mainstream media have called this project "controversial"...October 2, 2023 | theglobeandmail.comMedicure: Top 10 Undervalued Drug Manufacturers Industry Stocks (MPH)August 25, 2023 | theglobeandmail.comClosing Bell: Medicure Inc flat on Thursday (MPH)August 15, 2023 | theglobeandmail.comClosing Bell: Medicure Inc flat on Monday (MPH)July 29, 2023 | theglobeandmail.comClosing Bell: Medicure Inc flat on Friday (MPH)July 29, 2023 | finance.yahoo.comMedicure Reports Financial Results For Quarter Ended June 30, 2023July 24, 2023 | finance.yahoo.comMedicure to Present Financial Results on July 31, 2023 Call at 8:30 AM ET for Quarter Ended June 30, 2023May 26, 2023 | finance.yahoo.comMedicure Reports Financial Results for Quarter Ended March 31, 2023May 24, 2023 | theglobeandmail.comClosing Bell: Medicure Inc down on Tuesday (MPH)May 21, 2023 | finance.yahoo.comPoly Medicure Limited (POLYMED.NS)May 5, 2023 | theglobeandmail.comClosing Bell: Medicure Inc up on Friday (MPH)April 6, 2023 | finance.yahoo.comMedicure Reports Financial Results for Quarter and Year Ended December 31, 2022April 5, 2023 | finance.yahoo.comMedicure To Present Financial Results on April 10, 2023 Call at 8:30 AM ET for Quarter and Year Ended December 31, 2022February 1, 2023 | finance.yahoo.comMEDICURE ANNOUNCES RESIGNATION OF BOARD MEMBER AND GRANT OF STOCK OPTIONSNovember 25, 2022 | seekingalpha.comMedicure Inc. (MCUJF) Q3 2022 Earnings Call TranscriptNovember 24, 2022 | finance.yahoo.comMEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER ENDED SEPTEMBER 30, 2022November 18, 2022 | finance.yahoo.comMEDICURE TO PRESENT FINANCIAL RESULTS ON NOVEMBER 25, 2022 CALL at 8:30 AM ET FOR QUARTER ENDED SEPTEMBER 30, 2022October 19, 2022 | investing.comPoly Medicure Ltd (PLMD)September 26, 2022 | finance.yahoo.comEARLY WARNING NEWS RELEASE - DR. ALBERT D. FRIESEN'S HOLDINGS IN MEDICURE INC.See More Headlines Receive MCUJF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medicure and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/08/2024Today4/24/2024Next Earnings (Estimated)5/24/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolOTCMKTS:MCUJF CUSIPN/A CIK1133519 Webwww.medicure.com Phone(204) 487-7412Fax204-488-9823EmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.06) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-680,000.00 Net Margins-4.17% Pretax Margin-4.13% Return on Equity-4.29% Return on Assets-3.14% Debt Debt-to-Equity Ratio0.01 Current Ratio1.92 Quick Ratio1.55 Sales & Book Value Annual Sales$16.07 million Price / Sales0.44 Cash Flow$0.08 per share Price / Cash Flow8.34 Book Value$1.41 per share Price / Book0.48Miscellaneous Outstanding Shares10,440,000Free Float9,090,000Market Cap$7.10 million OptionableNot Optionable Beta0.92 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesDr. Albert David Friesen Ph.D. (Age 77)Founder, CEO & Chairman of the board Comp: $174.94kDr. Neil Owens Ph.D.President & COOMr. Haaris Uddin B.Com.CPA, Chief Financial OfficerDr. Reuben Saba Ph.D.Vice President of Scientific & Medical AffairsKey CompetitorsTrevenaNASDAQ:TRVNClever LeavesNASDAQ:CLVRCan-Fite BioPharmaNYSE:CANFInnovus PharmaceuticalsOTCMKTS:INNVDeFFECTOR TherapeuticsNASDAQ:EFTRView All Competitors MCUJF Stock Analysis - Frequently Asked Questions How have MCUJF shares performed in 2024? Medicure's stock was trading at $0.7754 at the start of the year. Since then, MCUJF shares have decreased by 12.3% and is now trading at $0.68. View the best growth stocks for 2024 here. Are investors shorting Medicure? Medicure saw a decrease in short interest during the month of March. As of March 15th, there was short interest totaling 6,500 shares, a decrease of 38.1% from the February 29th total of 10,500 shares. Based on an average daily trading volume, of 1,400 shares, the short-interest ratio is currently 4.6 days. View Medicure's Short Interest. When is Medicure's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, May 24th 2024. View our MCUJF earnings forecast. How were Medicure's earnings last quarter? Medicure Inc. (OTCMKTS:MCUJF) announced its earnings results on Monday, April, 8th. The company reported ($0.10) EPS for the quarter. The company earned $3.73 million during the quarter. Medicure had a negative net margin of 4.17% and a negative trailing twelve-month return on equity of 4.29%. How do I buy shares of Medicure? Shares of MCUJF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:MCUJF) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencySHOCKING Crypto Leak…Crypto 101 MediaThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”AltimetryBiden out June 13; Kamala won’t replace him?Paradigm PressThe Greatest Bull Market in Crypto History…Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medicure Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.